![]() ![]() |
|||||||||||
|
Alzheimer Hot Line 1-800-272-3900 Open 24 Hours a Day |
JOAN’S BLOG – WEDNESDAY/THURSDAY, MAY 21/22, 2008 – THE NEUROLOGY APPOINTMENT – I HATE THE MINI-MENTAL TEST!!!!/ POSSIBLE DRUG TRIAL FOR SID Wednesday was Sid’s neurology I couldn’t help myself – I brought that little peeve of mine to Dr. S’s attention, mainly because I felt he should know more accurately how Sid is functioning, what is stable, and what is slipping. He usually teases me about being so intense Because Sid was under 60 years of age when symptoms first occurred, and is only 65 now, Dr. S. would like to keep him stable, and hold off progression as long as possible, so he can live a longer, better life. Unfortunately, his diabetes and some of his medications have always excluded him from the drug trials. This time, there is a very promising vaccine trial for which he may be eligible. I have reservations about allowing Sid into the trial if he is eligible, (We find out on Friday) because of the previous problems with brain inflammation in the first trial. On the other hand, I don’t want to deprive him of the chance to improve. We were told he could drop out at any time, if he felt he did not want to continue. I would like to hear from those of you whose spouses have been involved in trials. Has anyone been in a vaccine trial? What did you think about it? Was it worth it? Did you see any improvement? Since I am woefully inadequate Amyloid Vaccine by Carl H. Sadowsky*, MD. FAAN “………….The culprit in Alzheimer’s disease is the overproduction and toxicity of a protein called beta amyloid 42…………….The vaccines developed to treat disease work by binding to and removing amyloid from the brain. The vaccines are basically antibodies to the amyloid protein. The antibody responders in the early vaccine trials demonstrated better outcomes on functional scales (e.g. handling money, use of the telephone and toileting) and less Alzheimer’s pathology in the brain then those patients that did not develop antibody. The initial ELAN trial (2005) used antibody to the entire beta amyloid 42 protein. Eighteen cases of brain inflammation (out of 300 patients) caused that trial to be discontinued. Current vaccine studies are now being started that are using antibodies that target smaller pieces of the amyloid protein. It is believed that these “shorter chain” antibodies will be able to remove amyloid from the brain and avoid the inflammatory reactions of the initial ELAN vaccine. …………..For information call Dr. E. Triana at 561-845-0500 ext. 211.” From September 10th, 2007 - Hippocampus - 6 Volume Issue 1 *Dr. Carl H. Sadowsky Please post comments under existing Message Board Topic: Drug Trials. Feedback to joan@thealzheimerspouse.com
The material included on this website contains general information intended as information only. This site is not intended to provide personal, professional, medical, or psychological advice, and should not be relied upon to govern behavior in any certain or particular circumstances. The opinions in the blogs are solely those of the owner of the website. The opinions on the message boards are not necessarily endorsed by the owner of this website, and are the opinions of those persons writing the messages. All material on this web site is for demonstration and informational purposes only.
The Alzheimer Spouse LLC 2009 All Rights Reserved
|
|
|||||||||